Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hydroxocobalamin + thiamin + pyridoxine
- Development stage
- Phase 4
- Lead developer
- Hospital Universitario Dr. Jose E. Gonzalez
- Modality
- Small Molecules
- Administration
- Intramuscular
01
Overview
This investigational multivitamin complex combination is being evaluated by the Hospital Universitario Dr. Jose E. Gonzalez (Universidad Autónoma de Nuevo León) for the treatment of pernicious anemia and megaloblastic anemia. The formulation consists of three active B-vitamins: hydroxocobalamin (vitamin B12) at a megadose of 10,000 mcg, thiamin (vitamin B1) at 100 mg, and pyridoxine (vitamin B6) at 50 mg, administered as a single intramuscular injection. Hydroxocobalamin serves as an essential cofactor for enzymes such as methionine synthase and methylmalonyl-CoA mutase, which are critical for DNA synthesis and erythropoiesis. Thiamin and pyridoxine support cellular metabolism and neurological health. The therapy is currently in a Phase 4 clinical trial (NCT03372447) to demonstrate the effectiveness of this single megadose approach in rapidly correcting vitamin deficiencies and improving hematological parameters in patients with megaloblastic anemia.
- Other names
- Hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mgMegadose of Hydroxocobalamin
02
Targets
MTR (Methionine synthase)DDC (Aromatic L-amino acid decarboxylase)MMUT (Methylmalonyl-coenzyme A mutase)TKT (Transketolase)PDH (Pyruvate dehydrogenase complex)
Beyond the preview
Go deeper on hydroxocobalamin + thiamin + pyridoxine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hydroxocobalamin + thiamin + pyridoxine.